产品

您的位置:首页 > 食品资讯 > 外讯导读 > 欧盟发布2019-2020人畜共患病细菌的抗菌素耐药性报告

欧盟发布2019-2020人畜共患病细菌的抗菌素耐药性报告

来源:好招商食品网 外讯导读   |  2024-04-25
   好招商食品网讯  2022年3月29日,欧盟食品安全局(EFSA)发布2019-2020人畜共患病细菌抗菌素耐药性(antimicrobial resistance ,AMR)的总结报告。
 
  部分原文报道如下:
 
  Data on antimicrobial resistance (AMR) in zoonotic and indicator bacteria from humans, animals and food are collected annually by the EU Member States (MSs), jointly analysed by the EFSA and the ECDC and reported in a yearly EU Summary Report. The annual monitoring of AMR in animals and food within the EU is targeted at selected animal species corresponding to the reporting year. The 2020 monitoring specifically focussed on poultry and their derived carcases/meat, while the monitoring performed in 2019 specifically focused on fattening pigs and calves under 1 year of age, as well as their derived carcases/meat. Monitoring and reporting of AMR in 2019–2020 included data regarding Salmonella, Campylobacter and indicator E. coli isolates, as well as data obtained from the specific monitoring of presumptive ESBL-/AmpC-/carbapenemase-producing E. coli isolates. Additionally, some MSs reported voluntary data on the occurrence of methicillin-resistant Staphylococcus aureus in animals and food, with some countries also providing data on antimicrobial susceptibility. This report provides an overview of the main findings of the 2019–2020 harmonised AMR monitoring in the main food-producing animal populations monitored, in carcase/meat samples and in humans. Where available, monitoring data obtained from pigs, calves, broilers, laying hens and turkeys, as well as from carcase/meat samples and humans were combined and compared at the EU level, with particular emphasis on multidrug resistance, complete susceptibility and combined resistance patterns to critically important antimicrobials, as well as Salmonella and E. coli isolates possessing ESBL-/AmpC-/carbapenemase phenotypes. The key outcome indicators for AMR in food-producing animals, such as complete susceptibility to the harmonised panel of antimicrobials in E. coli and the prevalence of ESBL-/AmpC-producing E. coli have been specifically analysed over the period 2014–2020.
 
  更多详情参见:https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2022.7209
 

TAGS:抗菌素 安全局 食品安全 细菌 欧盟
免责声明:本站部分文章转载自网络,图文仅供行业学习交流使用,不做任何商业用途。文章仅代表原作者个人观点,其原创性及文章内容中图文的真实性、完整性等未经本站核实,仅供读者参考。
上一篇: 欧盟食品安全局就膳食糖的安全摄入量发表科学意见
下一篇: 欧盟评估赖氨酸硫酸锰作为所有动物饲料添加剂的安全性和有效性